Roundtable on Obesity Solutions, Food and Nutrition Board, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine
GLP-1 secretion from peripheral tissues can also stimulate additional GLP-1 secretion in the brain despite its very short half-life
Experts say patients taking GLP-1-based medications should monitor for mood changes and report symptoms such as: New or worsening depression Anxiety or emotional changes Suicidal thoughts More research is needed to determine whether these drugs directly affect mood or whether changes are related to factors such as rapid weight loss, hormonal changes or other metabolic effects
GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound continue to grow in popularity among patients in Long Island and throughout New York
Through education and support services, we assist in making sustainable lifestyle changes that promote long-term health and well-being